000 01305 a2200373 4500
005 20250513115029.0
264 0 _c19970423
008 199704s 0 0 eng d
022 _a0039-6060
024 7 _a10.1016/s0039-6060(97)90316-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHill, G E
245 0 0 _aAprotinin is associated with a decrease in nitric oxide production during cardiopulmonary bypass.
_h[electronic resource]
260 _bSurgery
_cApr 1997
300 _a449-55 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650 0 4 _aAnimals
650 0 4 _aAprotinin
_xpharmacology
650 0 4 _aBlotting, Northern
650 0 4 _aCardiopulmonary Bypass
650 0 4 _aCell Line
_xdrug effects
650 0 4 _aHemostatics
_xpharmacology
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aLung
_xdrug effects
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aNitric Oxide
_xbiosynthesis
650 0 4 _aNitric Oxide Synthase
_xantagonists & inhibitors
700 1 _aSpringall, D R
700 1 _aRobbins, R A
773 0 _tSurgery
_gvol. 121
_gno. 4
_gp. 449-55
856 4 0 _uhttps://doi.org/10.1016/s0039-6060(97)90316-0
_zAvailable from publisher's website
999 _c9104402
_d9104402